Hong Kong vs Malawi: HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong
100.0%
in 2024
Malawi
100.0%
in 2024
Hong Kong rank
1st
Malawi rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong
- Malawi
How they compare
Hong Kong currently reports 100.0% against 100.0% in Malawi, a difference of 0.0%.
The two have swapped places 1 time across 17 shared years of data; in 2003 it was Hong Kong ahead.
Hong Kong ranks 1st and Malawi ranks 1st of 144 countries.
Across the 3 decades both report, Hong Kong averaged higher in 1 and Malawi in 2.
Head to head by decade
| Decade | Hong Kong | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.0% | 35.3% | 18.7% | Hong Kong |
| 2010s | 31.1% | 89.0% | 57.9% | Malawi |
| 2020s | 92.2% | 99.4% | 7.2% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong or Malawi?
- Hong Kong, at 100.0% against 100.0% in Malawi as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong and Malawi?
- 0.0%, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and Malawi?
- 17 years are reported by both, from 2003 to 2024.
- How do Hong Kong and Malawi rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong ranks 1st and Malawi ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.